To ensure the quality of animal models used in biomedical research we have developed a number of diagnostic testing strategies and methods to determine if animals have been exposed to adventitious infectious agents (viruses, mycoplasma, and other fastidious microorganisms). Infections of immunocompetent animals are generally transient, yet serum antibody responses to infection often can be detected within days to weeks and persist throughout the life of the host. Serology is the primary diagnostic methodology by which laboratory animals are monitored. Historically the indirect enzyme-linked immunosorbent assay (ELISA) has been the main screening method for serosurveillance. The ELISA is performed as a singleplex, in which one microbial antigen-antibody reaction is measured per well. In comparison the MFIA is performed as a multiplexed assay. Since the microspheres come in 100 distinct color sets, as many as 100 different assays can be performed simultaneously in a single microplate well. This innovation decreases the amount of serum, reagents and disposables required for routine testing while increasing the amount of information obtained from a single test well. In addition, we are able to incorporate multiple internal control beads to verify sample and system suitability and thereby assure the accuracy of results. These include tissue control and IgG anti-test serum species immunoglobulin (αIg) coated bead sets to evaluate sample suitability. As in the ELISA and IFA, the tissue control detects non-specific binding of serum immunoglobulin. The αIg control (Serum control) confirms that serum has been added and contains a sufficient immunoglobulin concentration while the IgG control bead (System Suitability control), coated with serum species immunoglobulin, demonstrates that the labeled reagents and Luminex reader are functioning properly.
1. The MFIA requires Charles River's antigen coated polystyrene microspheres (beads), test sera, labeled reagents (BAG, SPE) and buffers (Primary Diluent, Assay buffer). 2. The reagents are added stepwise to the wells of 96-well filter-bottom microtiter plates. 3. The MFIA is performed as a heterogeneous test meaning incubations are followed by filter-wash steps to remove unbound serum constituents or labeled reagents. Wash solution added to plate wells is removed by aspiration through well filter-bottoms, which retain the beads. 4. The MFIA assays are performed at room temperature (27°C+/-2°C). 5. Antigen-antibody complexes formed during the test serum incubation step are detected by incubations with biotinylated goat anti-species conjugates (BAG) followed by R-phycoerythrin-labeled streptavidin (SPE). 6. In the assay reader, the beads pass one at a time through a detector where they are exposed to two lasers. One laser excites the internal dyes that identify the bead's color set, which corresponds to an assay; the other excites the phycoerythrin reporter dye captured during the assay. A predetermined number of beads are read per assay and the intensity of phycoerythrin fluorescence is reported as a Median Fluorescence Index (MFI). Figure 1 . MFIA Procedure. The xMAP-based MFIA is a suspension microarray which utilizes color-coded polystyrene 5.6 micron beads to which antigens (or controls) are covalently linked. Since the beads come in 100 distinct color sets, as many as 100 different assays can be performed in a single well Assay steps are performed in filter-bottom microtiter plates so that beads can be washed by aspiration on a vacuum manifold. Reactions are read with the Luminex xMAP 100 fluorometer. The intensity of phycoerythrin fluorescence is reported as a median fluorescence index (MFI)
Before Getting Started Please Note the Following:
1. The MFIA beads are light sensitive 1. Limiting the amount of direct light exposure is crucial. The normal amount of light exposure that occurs during routine testing is acceptable but prolonged exposure can lead to photobleaching of the beads which render them unreadable by the Assay reader. 2. It is crucial to the success of the assay that the MFIA beads are always vortexed into suspension and then sonicated (10-30 seconds) prior to use. 3. The Assay reader gathers information from single beads only. Aggregated bead clusters can lead to longer read times.
2. Be sure to keep the test plate covered with the plate lid during all incubation steps to avoid evaporation of assay solutions. 3. Personal Protective Equipment required: Laboratory coat, gloves and eye protection should be worn at all times while working in a laboratory setting.
Reagents
1. Table 1 includes most of the materials necessary to establish an in-house MFIA laboratory. Additional or duplicate items may be necessary depending on your specific needs. Please note that this inventory excludes reagents purchased from Charles River (MFIA beads, controls and supplemental reagents). Several commercial sources of biotinylated conjugates and streptavidin tagged phycoerythrin are available. However the reagents available from Charles River have been titrated to yield the optimal signal to noise score with our reagents, using alternative vendors or reagent lots is not recommended. 
Sample Preparation
1. Assemble your testing materials, reagents and disposables. 1. Multi-and single-channel micropipettes and tips 2. 96-well low protein binding microtiter plates (serum dilutions) and filter-bottom plates (MFIA assay) 3. Collect blood specimens according to your standard procedure. Allow the blood specimens to clot fully by holding them at room temperature for at least 30 minutes before centrifugation and serum removal. Undilute serum should be vortexed briefly to mix the serum components prior to sampling. 4. The final testing dilution for the MFIA is 1/50. It is necessary to make a 2X (1/25) sample of your test serum for the assay. Dilute the undiluted test sera by adding 1 part serum to 24 parts MFIA Primary Diluent. Organization of your test serum in a 96-well microtiter plate greatly reduces the transfer time of your samples to the test plate and is highly recommended.
Test Plate Preparation
1. Pre-wetting the 96-well Test plate is required to insure proper, even well evacuation. Even if the entire plate will not be used this step is initially required, you will not have to add subsequent reagent or wash buffer to the empty wells. 1. Some labs run less than a full 96-well plate by sealing off the unused wells on the test plate and plan to re-use these wells at a later date. We do not recommend using this method since it may affect the proper filtration of the test plate.
2. Proper test plate aspiration is crucial to the success of the MFIA assay. Evacuation of the sample wells should take approximately 5-10 seconds. Aspirating the well contents too quickly can lead to bead aggregation and slow read times at the end of the assay. 3. Blot the underside of the test plate with paper towels after every wash step to ensure liquid drainage has stopped. Failure to blot the test plate can lead to liquid reagents wicking out of the wells during incubation and result in failing Goat anti-species and/or Species IgG bead scores.
Representative Results

1.
A minimum number of beads are read per assay and the intensity of phycoerythrin fluorescence is reported as a Median Fluorescence Index (MFI) ranging from 0 to 32,667. After comparing counts of 25, 50 or 100 beads per well we saw no statistical difference and routinely count 25 beads per agent per sample well. Examine the results report for errors, such as inadequate bead counts or failing IgG / anti-IgG bead scores. These beads are designed to 'score' within a pre-determined MFI range when the appropriate amount of primary serum and labeled reagents are added to each well. Sample wells with errors, (low bead counts) or failing IgG control bead scores should be repeated to acquire valid results. 2. Export the results to an Excel worksheet. For our data interpretation each assay is assigned:
1. A Tissue Control (TC) Test: For most rodent MFIA assays, the tissue control is an extract of wild-type baculovirus-infected insect cells.
2. An Assay Cutoff: This value is the minimum fluorescence expected and is adjusted for each assay to maximize diagnostic accuracy. For most assays, the fluorescence cutoff is 3000. Ig Bead Set* ≥ Cutoff/1000 Pass *Bead set coated with species-specific anti-test serum immunoglobulin (Ig): failing scores for this sample suitability control could result from the addition of insufficient sample, too high a sample dilution, incorrect species or testing serum from an immunodeficient host.
2. If any of the Test Plate Assay Controls fail except the High Range Immune Serum, the results are not acceptable and must be repeated. Passing Low range Serum control scores are critical since it demonstrates the detection sensitivity level of the test plate. 3. The Goat anti-species IgG bead score is based on the amount of primary test serum added to the assay. If this control bead fails but the species IgG passes (Well B1, Fig.3 ) then it indicates that enough testing reagents (BAG, SPE) were added to the test well and it is a serum related issue. If the amount of testing reagents is insufficient in a particular well both the IgG and anti-IgG control beads will fail (Well E1, Fig.3 ). Table 3 . It is critical to confirm any borderline or positive finding by an alternative test method. 
Discussion
The MFIA testing process is highly efficient, requiring less equipment and smaller sample and reagent volumes than traditional singleplex tests. The functionality of the multiplex system gives the user the flexibility to screen simultaneously for multiple strains or serotypes of common agents in laboratory rodents (i.e. Coronavirus, parvoviruses etc.). This also enables us, to design customized bead panels based on the area of interest (ie. specific virus family) and is adaptable to screening other types of biomolecules including cytokines and other biomarkers. In addition, it allows us to incorporate several internal control assays to verify sample and system suitability and thereby assure the accuracy of results. These include tissue control and IgG anti-test serum species immunoglobulin (αIg) coated bead sets to evaluate sample suitability. A tissue control bead detects non-specific binding of serum immunoglobulin and the αIg bead control confirms that serum has been added and contains a sufficient immunoglobulin concentration. Another control bead, coated with serum species immunoglobulin, demonstrates that the labeled reagents and assay reader are functioning properly. Other commercially available multiplex format serologic assays (ie. MicroArrays, ImmunoComb) may not offer this same level of result confirmation.
The ability to narrow down the possible source of assay failure prior to retesting can help an investigator save on time and materials. Critical aspects of the MFIA should be confirmed before repeating a failed sample. Since the assay is conducted at ambient temperature it should be verified that the laboratory temperature is approximately 27°C±2°C, higher temperatures can lead to lower than expected scores for controls and samples. Washing is perhaps the most critical step in the assay. Insuring that the test plate is properly washed, blotted and resuspended can eliminate the vast majority of sampling errors due to low bead count (due to aggregated beads) or insufficient reagent addition (lost by wicking out of test plate filter bottom). We routinely count 25 beads per assay (agent) and have found no statistical difference in the results by counting higher number of beads which will also lead to a longer read time for the plate.
We have performed comprehensive validation studies of MFIA on several species of commonly used laboratory animals (Mouse, Rat, Hamster, Guinea Pig and Rabbit) to demonstrate diagnostic accuracy, reproducibility, and ruggedness by testing large numbers of known positive and negative serum samples, and comparing their ELISA, IFA and MFIA results. The detection limits (i.e., standard immune serum titration endpoints) of MFIA were comparable to, and in some cases surpassed, those of corresponding ELISA. Diagnostic specificity, measured with
